Onartuzumab

Onartuzumab?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target scatter factor receptor kinase
Clinical data
Identifiers
1133766-06-9 
None
UNII MS1J9720WC Yes
Chemical data
Formula C4422H6820N1168O1363S31
99.1 kDa
  (what is this?)  (verify)

Onartuzumab is a humanized monoclonal antibody designed for the treatment of cancer.[1]

Onartuzumab was developed by Genentech, Inc.

References

  1. "Statement On A Nonproprietary Name Adopted By The USAN Council: Onartuzumab" (PDF). American Medical Association.